Patents by Inventor Béatrice Riteau

Béatrice Riteau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PAR-4 ANTAGONISTS FOR USE IN THE TREATMENT OR PREVENTION OF INFLUENZA VIRUS TYPE A INFECTIONS
    Publication number: 20160095897
    Abstract: The present invention provides methods and compositions (such as pharmaceutical compositions) comprising PAR4 antagonists for treating or preventing influenza virus type A infections, in particular H1N1 infection. PAR4 antagonists may be combined with a PAR2 agonist or a PAR1 antagonist.
    Type: Application
    Filed: April 22, 2014
    Publication date: April 7, 2016
    Inventors: Beatrice RITEAU, Ba Vuong LE, Bruno LINA
  • PAR2 agonists for use in the treatment or prevention of influenza virus type A infections
    Patent number: 9125861
    Abstract: Methods and compositions (such as pharmaceutical compositions) for treating influenza virus type A infections in human subjects include PAR2 agonists being administered to the subject. The PAR2 agonists include small organic molecules, antibodies, and aptamers. In addition, the PAR2 agonist may be a PAR2 activating peptide. Exemplary PAR2 activating peptides include SLIGRL (SEQ ID NO: 1) and SLIGKV (SEQ ID NO: 2).
    Type: Grant
    Filed: May 3, 2010
    Date of Patent: September 8, 2015
    Assignees: Institut National de la Sante et de la Recherche Medicale (INSERM), Institut National de la Recherche Agronomique (INRA)
    Inventors: Nathalie Vergnolle, Beatrice Riteau
  • Par1 Inhibitors for Use in the Treatment or Prevention of Paramyxoviridae Infections
    Publication number: 20140378502
    Abstract: The present invention is concerned with the use of Protease-Activated Receptor-1 (PAR1) inhibitors for preventing or treating a Paramyxoviridae infection in a subject. Described herein are methods, compounds and pharmaceutical compositions useful in addressing such infections, and more particularly infections from human respiratory syncytial virus (hRSV) and human metapneumovirus (hMPV).
    Type: Application
    Filed: May 11, 2012
    Publication date: December 25, 2014
    Applicants: Université Laval, Institut National de la Recherche Agronomique
    Inventors: Béatrice Riteau, Guy Boivin, Laetitia Aerts, Marie-Eve Hamelin
  • PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
    Publication number: 20140308296
    Abstract: The present invention provides methods and compositions (such as pharmaceutical compositions) comprising PAR1 antagonists for treating or preventing influenza virus type A infections, in particular H1N1 infection. PAR1 antagonists may be combined with a PAR2 agonist.
    Type: Application
    Filed: June 23, 2014
    Publication date: October 16, 2014
    Inventors: Béatrice Riteau, Khaled Khoufache
  • PAR-1 antagonists for use in the treatment or prevention of influenza virus type A infections
    Patent number: 8802623
    Abstract: The present invention provides methods and compositions (such as pharmaceutical compositions) comprising PAR1 antagonists for treating or preventing influenza virus type A infections, in particular H1N1 infection. PAR1 antagonists may be combined with a PAR2 agonist.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: August 12, 2014
    Assignee: Institut National de la Recherche Agronomique
    Inventors: Béatrice Riteau, Khaled Khoufache
  • PAR-1 Antagonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
    Publication number: 20120213802
    Abstract: The present invention provides methods and compositions (such as pharmaceutical compositions) comprising PAR1 antagonists for treating or preventing influenza virus type A infections, in particular H1N1 infection. PAR1 antagonists may be combined with a PAR2 agonist.
    Type: Application
    Filed: November 15, 2010
    Publication date: August 23, 2012
    Inventors: Béatrice Riteau, Khaled Khoufache
  • PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
    Publication number: 20120058127
    Abstract: The present invention provides methods and compositions (such as pharmaceutical compositions) for treating or preventing influenza virus type A infections. More particularly, the invention relates to a PAR2 agonist for use in the treatment or prevention of an influenza virus type A infection.
    Type: Application
    Filed: May 3, 2010
    Publication date: March 8, 2012
    Inventors: Nathalie Vergnolle, Béatrice Riteau